Lung Cancer Clinical Trials in San Antonio, TX

Lung Cancer Clinical Trials in San Antonio, TX

View the best 10 lung cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Lung Cancer clinical trial.

Trials in San Antonio, Texas

Here are the top 10 medical studies for lung cancer in San Antonio, Texas

Image of Carolina BioOncology Institute /ID# 232597 in Huntersville, United States.

ABBV-514 +2 More

Immunotherapy

Recruiting1 awardPhase 1
This trial is testing two experimental drugs, ABBV-514 and Budigalimab, on adults with specific types of cancer. The goal is to find out if these drugs can help treat lung and head/neck cancers by monitoring their effects and side effects.
Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.

PF-06821497

BCL-2 Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.
Image of University of California, Los Angeles in Los Angeles, United States.

DS-1062a

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests a new drug, DS-1062a, on patients with advanced cancers who haven't been cured by other treatments. The goal is to find the safest dose and see if the drug can help treat these cancers.
Image of Carta - Clinical Associates in Research Therapeutics of America, LLC in San Antonio, United States.

Ponsegromab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial tests Ponsegromab, a new drug, on cancer patients who are losing weight and have high GDF 15 levels. The drug aims to lower GDF 15 to improve appetite and reduce weight loss.
Image of University of California San Diego, 3855 Health Sciences Drive, Mc 0987 in La Jolla, United States.

Itacitinib +1 More

Janus Kinase (JAK) Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing the safety of using two drugs, itacitinib and osimertinib, together. The study focuses on patients with advanced lung cancer that has spread. Itacitinib helps the immune system fight cancer, while osimertinib targets and kills specific cancer cells. Osimertinib is approved for treating a specific type of lung cancer, even in cases where the cancer has become resistant to other treatments.
Image of Research Site in Mesa, United States.

Durvalumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new immunotherapy drug combo to see if it's more effective than just one of the drugs for treating lung cancer that has spread and can't be removed by surgery.
Image of Arizona Oncology Assoc, Pc-Hal in Phoenix, United States.

Carboplatin +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a new way to treat lung cancer that may be more effective and have fewer side effects than the current standard of care.
Image of Research Site in Phoenix, United States.

Carboplatin +4 More

Chemotherapy

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment combining a drug called durvalumab with chemotherapy. The study will compare how well the new treatment works compared to chemotherapy alone.
Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of Arizona Oncology Associates, PC - HOPE in Tucson, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer, including metastatic cancer that has progressed after PD-1 inhibitor treatment. The study will also find out what side effects occur.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.